CHICAGO, ILLINOIS–Dec 4, 2008 — Dexas Pharmaceutical Sciences is very proud to have established a strategic alliance with V.A.M.P. (Erlangen, Germany) one of the pioneers of micro computed tomography development. Dexas will distribute V.A.M.P.’s TomoScope&re…
Devices, Radiology
Dexas Clinical Sciences, micro computed tomography, micro-CT, TomoScope
Posts on ‘December 4th, 2008’
New High Speed and High Resolution Micro CT to be Introduced Into North American Market
NovaRx Appoints Industry Veteran as President and COO
SAN DIEGO, Dec. 4 (HSMN NewsFeed) — NovaRx Corporation announced today the appointment of Norrie J.W. Russell, Ph.D to the career opportunity of President and Chief Operating Officer. Dr. Russell brings to the company more than 25 years experience in drug discove…
Biopharmaceuticals, Personnel
NovaRx
Azur Pharma Ltd. Enters Into Definitive Agreement With BioSante Pharmaceuticals Inc [nasdaq: BPAX], to Acquire U.S. Rights to Elestrin (TM)
DUBLIN, December 4 (HSMN NewsFeed) — Azur Pharma Limited ("Azur") today announced that it has entered into a definitive agreement with BioSante Pharmaceuticals, Inc ("BioSante")(Nasdaq: BPAX ) to acquire U.S. rights to Elestrin(TM). …
Biopharmaceuticals, Acquisitions
Azur Pharma, BioSante Pharmaceuticals, Elestrin, estradiol
Broncus Technologies Secures $38 Million in Funding Round Led by Ares Life Sciences
MOUNTAIN VIEW, CA–Dec 4, 2008 — Broncus Technologies, Inc., a medical device company developing products for emphysema and other lung diseases, announced today that it has closed a $38 million round of Series G funding, led by a $25 million investment fr…
Devices, Venture Capital
Broncus Technologies

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.